Sweet's syndrome (the eponym for acute febrile neutrophilic dermatosis) is characterized by a constellation of clinical symptoms, physical features, and pathologic findings which include fever, neutrophilia, tender erythematous skin lesions (papules, nodules, and plaques), and a diffuse infiltrate consisting predominantly of mature neutrophils that are typically located in the upper dermis without vasculitis.
Age and Sex distribution
All patients were between 22-73 years (mean 46.53±18.55) of age. There were 9 females (35 days to 57 years) and three males (10-40 years) and the female to male ratio was 3: 1.
Duration of disease
The mean duration of the disease was 3-8days (mean 6.08±1.62)
Cutaneous/ extracutaneous lesions and systemic features
All patients presented with multiple, typical, tender erythematous skin lesions including papules, nodules, and plaques with pseudovesiculations. The lesions were bilaterally symmetrical involving the hands, forearms, arms, legs, and thighs in 8/12(66.6%) patients. The trunk was involved in 6/12 (50%), face in 6/12 (50%) and the genitalia was involved in 1/12(8.33%) patient.
1 patient presented with localised sweets syndrome involving the right forearm. Constitutional symptoms of fever (temperature ≥38 °C) and myalgia was present in all patients.
Associated comorbidity and Drug intake
History of upper respiratory tract infection, pain abdomen, pain over the bilateral hip joint and loose motion was present in 1(8.33%) patient each. 1 patient also presented with history of lesions during the third trimester of pregnancy with fetus loss at 35 weeks of gestation. Drug history of ciprofloxacin intake was present in 1 patient.
Laboratory Findings
Haemoglobin (Hb)d" 9gm% was present in 2/ 12(16.6%) patients while an erythrocyte sedimentation rate (ESR) of ≥ 20 mm was present in 11/12( 91.6%) patients. 9/12 (75%) patients presented with a total leucocyte count (TLC) ≥ 8000/cm 3 and absolute neutrophil count ≥ 70%. Elevated C reactive protein d" 8mg/L was also present in 8/12 (66.6%) patients.
( Table 3 )
Histopathologic Findings
All patients underwent skin biopsies and had histological findings of a dense neutrophilic infiltrate within the dermis and the absence of leukocytoclasis.
( Fig 2 and 3)
Treatment and Clinical Course
Nine out of twelve (75%) patients were started on oral corticosteroids with clinical response seen in 1-3 weeks (mean 2.11 ± 0.78days). Intravenous dexamethasone was started in 3/12 (25%) patients.
Complete resolution was seen in 7/12 (58.33%) patients while partial resolution of lesions was seen in 5/12 (41.66%) patients after commencing of the therapy.
Discussion
The syndrome was originally described by Dr. Robert Sciences-Nepal,2011,Vol-7,No-3 The most frequently affected sites of SS are known to be the upper extremities, head and neck. 2, 3, 6 The upper extremities were almost universally involved in our study population, seen in 66.6% of the patients. (Table 1) Fever was the most common symptom in this report seen in all patients, which was comparable to the study done by Anavekar et al 8 Although the etiology of SS is unknown, an immunologic mechanism with an abnormal tissue response to certain unknown antigens may play a role.
A hypersensitivity reaction to an eliciting bacterial, viral, or tumor antigen may promote the development of The response to prednisolone in this report was prompt, 
